MyHeritage Buys Promethease and SNPedia

myheritageMyHeritage, a global discovery platform for exploring family history and gaining health insights, acquired River Road Bio, the company that owned and operated SNPedia and Promethease.

The amount of the deal was not disclosed.

Launched in 2006, SNPedia.com is a wiki that contains a broad, community-curated knowledge base linking between genetic variants and medical conditions, as well as traits, citing over 30,000 peer-reviewed scientific publications. SNPedia is the primary encyclopedia and de facto go-to resource for information about genetic markers, and has evolved to cover 110,413 genetic variants. It operates under a Creative Commons license, wherein it is a free resource for academic and non-commercial use, with only MyHeritage having the right to utilize it commercially.
MyHeritage plans to maintain SNPedia as a free resource under the same terms, and will utilize this comprehensive knowledge base to enhance future versions of MyHeritage’s DNA health products.

Launched in 2008, Promethease.com is a literature retrieval service which allows consumers to upload their raw DNA data (from services such as Ancestry.com, 23andMe, and others) and automatically compare it to SNPedia to see relevant scientific findings regarding their genome. The Promethease service currently costs $12, and offers consumers the option to store their DNA data.
It currently contains hundreds of thousands of raw DNA files uploaded by customers who have tested with services such as Ancestry.com, 23andMe, and FamilyTreeDNA.

MyHeritage is a global discovery platform for exploring family history, uncovering ethnic origins, finding new relatives, and gaining health insights
Launched in 2016, MyHeritage DNA is one of the world’s largest consumer DNA databases, with more than 3 million people, and it is about to grow further following the acquisition of Promethease by MyHeritage.
Available in 42 languages, MyHeritage has 104 million registered users, 45 million family trees, and nearly 10 billion historical records.

MyHeritage intends to keep Promethease separate from its MyHeritage DNA health product line.

FinSMEs

09/09/2019

Join the discussion